| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 5.355 | 27.646 | 41.859 | 30.280 | 25.463 | 63.320 | 62.005 |
| Total Income - EUR | - | - | 0 | 22.621 | 31.349 | 47.219 | 35.149 | 30.806 | 68.804 | 62.005 |
| Total Expenses - EUR | - | - | 2.144 | 21.384 | 29.664 | 33.800 | 30.848 | 33.321 | 44.332 | 59.637 |
| Gross Profit/Loss - EUR | - | - | -2.144 | 1.238 | 1.685 | 13.419 | 4.301 | -2.515 | 24.472 | 2.367 |
| Net Profit/Loss - EUR | - | - | -2.144 | 1.187 | 1.409 | 13.001 | 3.949 | -2.769 | 23.784 | 507 |
| Employees | - | - | 0 | 2 | 2 | 0 | 0 | 2 | 2 | 2 |
Check the financial reports for the company - Lorliv Alternmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 30.570 | 34.310 | 28.181 | 22.950 | 20.015 | 15.174 | 15.023 | 12.278 |
| Current Assets | - | - | 2.187 | 113 | 1.453 | 10.771 | 16.182 | 2.887 | 5.810 | 13.183 |
| Inventories | - | - | 0 | 0 | 1.140 | 0 | 0 | 0 | 3.338 | 3.721 |
| Receivables | - | - | 0 | 0 | 0 | 9.471 | 7.947 | 1.128 | 1.171 | 602 |
| Cash | - | - | 2.187 | 113 | 312 | 1.300 | 8.235 | 1.759 | 1.302 | 8.860 |
| Shareholders Funds | - | - | -2.100 | -874 | 551 | 13.542 | 4.487 | 1.471 | 4.545 | 5.199 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 34.857 | 13.460 | 11.372 | 8.166 | 24.832 | 15.032 | 16.288 | 20.262 |
| Income in Advance | - | - | 0 | 21.836 | 17.710 | 12.014 | 6.879 | 1.558 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Lorliv Alternmed Srl